Mbc Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 21-12-2024
- Paid Up Capital ₹ 0.10 M
as on 21-12-2024
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Revenue %
(FY 2019)
- Profit 2441.84%
(FY 2019)
- Net Worth 12.04%
(FY 2019)
- Total Assets 3300.76%
(FY 2019)
About Mbc Life Sciences
The Corporate was formerly known as Subhlaxmi Jewels Private Limited. The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mayur Batra and Anshu Batra serve as directors at the Company.
- CIN/LLPIN
U51100DL2009PTC188431
- Company No.
188431
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2009
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mbc Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mayur Batra  | Director | 16-Mar-2009 | Current |
| Anshu Batra | Director | 16-Mar-2009 | Current |
Financial Performance of Mbc Life Sciences.
Mbc Life Sciences Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 2441.84% increase in profit. The company's net worth Soared by an impressive increase of 12.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mbc Life Sciences?
In 2017, Mbc Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Proactive Universal Trading Company Private LimitedActive 16 years 4 monthsMayur Batra is a mutual person
- Pug Commodities Private LimitedActive 23 years 4 months
Mayur Batra and Anshu Batra are mutual person
- Sab Real Estates Private LimitedActive 23 years 4 months
Mayur Batra and Anshu Batra are mutual person
- Mbc Business Consultants And Trading Private LimitedActive 17 years 3 months
Mayur Batra is a mutual person
- Lancers Consultants Private LimitedActive 36 years 3 months
Mayur Batra and Anshu Batra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mbc Life Sciences?
Unlock and access historical data on people associated with Mbc Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mbc Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mbc Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
